|
Press Release and News
September 11, 2012
Indel Therapeutics Named Industry Partner for New Genomics Research Project
February 27, 2012
Indel Therapeutics Awarded Third Patent for Novel Antimicrobial Drug Discovery Platform
December 08, 2011
Indel Therapeutics Awarded Key Patent for Novel Antimicrobial Drug Discovery Platform
April 28, 2011
Indel Raises second financing and Allan Collings joining board of directors
September 24, 2009
Finalist for the New Ventures BC Competition - One of top ten companies selected as a finalist
August 11, 2009
Indel Therapeutics Awarded Key Platform Patent for Novel Antimicrobial Drug Discovery Platform Technology
July 15, 2009
Dr. Patrick Scannon joins Indel Therapeutics Board of Directors
January 14, 2009
Formation of Scientific Advisory Board
September 29, 2008
Indel selected as Canada’s Top 10™ Life Science Company for 2008-2009
September 24, 2008
Indel Closes Financing and Establishes Board of Directors
September 18, 2008
Selected as Red Herring Top 50 Company in Canada
August 19, 2008
Formation of Indel Therapeutics Inc.
|